Evolus, Inc. (EOLS)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$7.91
-4.12%
Mkt Cap $517.62M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (8 analysts)
$18.40
Range $13.00 – $27.00
Implied Upside
+132.6%
Consensus $18.40 vs current $7.91